GENB:NASDAQ
Generate Biomedicines Inc
$13.92
arrow_upward
+1.68%(+0.23) 1D
Oct 5, 1:46:58 PM GMT-4 · USD
search
All symbols
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for GENB...
Open
$13.71
High
$14.06
Low
$13.45
Mkt. cap
1.79B
Avg. vol.
1.53M
Volume
584.96K
52-wk high
$22.67
52-wk low
$11.00
No. of employees
312
Open
$13.71
High
$14.06
Low
$13.45
Mkt. cap
1.79B
Avg. vol.
1.53M
Volume
584.96K
52-wk high
$22.67
52-wk low
$11.00
No. of employees
312
News stories
From web sources and news partners
Investing.com
·
6 hours ago
Generate Biomedicines stock rating reiterated at Buy by H.C. Wainwright on cancer trial progress
Profile
Generate:Biomedicines is a biotechnology company founded in 2018 and headquartered in Somerville, Massachusetts. It specializes in using machine learning to design and optimize proteins for therapeutic applications, with a focus on immunology, oncology, and infectious diseases. Wikipedia
About Generate Biomedicines Inc
CEO-
Employees312
Founded2018
HeadquartersSomerville, Massachusetts, United States
SectorBiotechnology
Websitegeneratebiomedicines.com